2013
DOI: 10.1074/jbc.m112.446492
|View full text |Cite
|
Sign up to set email alerts
|

Phosphodeoxyribosyltransferases, Designed Enzymes for Deoxyribonucleotides Synthesis

Abstract: Background:The nucleoside deoxyribosyltransferase family contains hydrolases and transferases with different substrate specificities. Results: Chimeras exchange deoxyribose 5-(mono, di, and tri)-phosphate between natural bases and analogues. Conclusion: Comparison of the structures and catalytic mechanisms of members of the nucleoside deoxyribosyltransferase family allows the design of unprecedented enzymes.Significance: Phosphodeoxyribosyltransferases open the road to new deoxyribonucleotides synthetic pathwa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 48 publications
(44 reference statements)
0
8
0
Order By: Relevance
“…Mechanistically, the hydrolysis of substrates in both enzymes proceeds through the formation of an α-deoxyribose-5-phosphate-enzyme covalent intermediate via a conserved glutamate residue. The new variants are able to transfer α-deoxyribose 5-phosphate, α-deoxyribose 5-triphosphate or α-deoxyribose 5-O-(1-thiotriphosphate) between cytosine or adenine, and modified nucleobases like 5-fluorouracil, 5-bromouracil, 2,6-diaminopurine, 6-chloropurine, and 2,6-dichloropurine (Kaminski and Labesse, 2013) with varying degree of efficacy (Scheme 24).…”
Section: Monophosphatesmentioning
confidence: 98%
See 1 more Smart Citation
“…Mechanistically, the hydrolysis of substrates in both enzymes proceeds through the formation of an α-deoxyribose-5-phosphate-enzyme covalent intermediate via a conserved glutamate residue. The new variants are able to transfer α-deoxyribose 5-phosphate, α-deoxyribose 5-triphosphate or α-deoxyribose 5-O-(1-thiotriphosphate) between cytosine or adenine, and modified nucleobases like 5-fluorouracil, 5-bromouracil, 2,6-diaminopurine, 6-chloropurine, and 2,6-dichloropurine (Kaminski and Labesse, 2013) with varying degree of efficacy (Scheme 24).…”
Section: Monophosphatesmentioning
confidence: 98%
“…A new chimeric enzyme with phosphodeoxyribosyltransferase activity was built through a structure-based design by Kaminski and Labesse (2013) using two distantly related enzymes: nucleoside deoxyribosyltransferase (EC 2.4.2.6) from Lactobacilli and deoxyribonucleoside 5′-nucleotide nucleosidase (EC 3.2.2.-) from rat. The concept was based on several structural similarities shared by both enzymes, such as the adoption of a Rossmann fold and a common catalytic triad.…”
Section: Monophosphatesmentioning
confidence: 99%
“…It is known that sulfate ions usually interact with sites of protein for binding of phosphate groups, including internucleoside phosphate groups of DNA [51][52][53]. The analysis of the available crystalline structures of the LA in the PDB database made it possible to detect the presence of two sites of LA binding sulfate ions (PDB 1HML and 3B0I structures).…”
Section: Construction Of the Model Of La Interaction With Onsmentioning
confidence: 99%
“…For example, 2,6-diaminopurine-deoxynucleoside-5'-monophosphate (dDAMP) was deaminated via adenylate deaminase to form dGMP. Recently, a new active chimera phosphodeoxyribosyltransferase (PDTase) was designed to convert guanine into dGMP from dAMP [6]. However, in these novel processes, dGMP could not be produced in large scales because the original substrates were too expensive.…”
Section: Introductionmentioning
confidence: 99%